Permanent Birth Control Drugs Market

Permanent Birth Control Drugs Market

Category : Healthcare & Life Sciences Reports | Delivery Format : PDF,PPT | Publisher: Reports and Insights | Pages : 200

To learn more about this report, request a free sample copy

Permanent Birth Control Drugs Market Overview

The report is titled as ‘Permanent Birth Control Drugs Market: Opportunity Analysis and Future Assessment 2020-2028’. An overview of conceptual frameworks, analytical approaches of the permanent birth control drugs market is the main objective of the report, which further consists the market opportunity and insights of the data involved in the making of the respective market. The permanent birth control drugs market is expected to grow at a significant rate in the near future.

The global permanent birth control drugs market in 2020 is estimated for more than US$ 38,161.4 Mn and expected to reach a value of US$ 62,857.4 Mn by 2028 with a significant CAGR of 6.4%.

Permanent Birth Control Drugs Introduction

Birth control is a method of preventing pregnancy using drugs or a device. It is also known as contraception and fertility control. In order to prevent pregnancy devices used in contraception interfere along with normal process of sperm-ovum fertilization.

Percentage of permanent birth control drug use by region image

Source: Department of Economic and Social Affairs Population Division 2015, United Nations

Permanent Birth Control Drugs Market Dynamics

Increasing attention towards the prevention of unintended pregnancy and family planning is one of the major factors that are expected to prompt the growth of the permanent birth control drugs market around the globe. According to the centers for disease control and prevention, in 2017, it was estimated that about 194,377 babies were born to women, aged 15-19 years, for a birth rate of 18.8 per 1,000 women, in this age group.

In addition, the increase in the use of contraception in young women along with the rise in higher educational attainment propels the target market growth.

Furthermore, health problems linked with under-age pregnancies can be reduced due to the increase in popularity of new era’s contraception methods, and the increase of contraceptive oral pills use as an important method to avoid unplanned pregnancy, which further boosts the growth in the global contraceptives market.

Moreover, government initiatives to spread awareness regarding population control is expected to support the growth of the target market in the near future.

However, risks related to the human health of using contraceptives, availability of alternate contraceptive methods, and lack of social acceptance is expected to undermine the growth of the permanent birth control drugs market.

Permanent Birth Control Drugs Market Segmentation

The permanent birth control drugs market is segmented on the basis of product, age group, education, end-user, and by region.

By Product

Drugs

Devices

Intrauterine Devices (IUDs)

Hormonal IUDs

Copper IUDs

Diaphragms

Sponges

Patches

Implants

Vaginal Rings

Others

By Age Group

15‐24 years

25‐34 years

35‐44 years

Above 44 years

By Education

Less than high school

High school graduate

College graduate

Other college degrees

By End User

Household

Hospitals

Clinics

By Region

North America

Europe

Asia Pacific

Latin America

Middle East

Africa

Permanent Birth Control Drugs Market Competitive Landscape

Some of the key participating players in the global permanent birth control drugs market are The Female Health Company, Teva Pharmaceutical Industries Limited, Mayer Laboratories Allergan plc, Bayer AG, Pfizer, Inc., Cooper Companies, Inc., Ansell LTD., Merck & Co., Inc., and Church & Dwight, Co., Inc.

Regional Segmentation

On the basis of region, the permanent birth control drugs market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa.

MMC Overview on Permanent Birth Control Drugs Market Report

The non-identical approach of Reports and Insights stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give better opportunity for the customers to put their effort.

A research report on the Permanent Birth Control Drugs market by Reports and Insights is an in-depth and extensive study of the market based on the necessary data crunching and statistical analysis. It provides a brief view of the dynamics flowing through the market, which includes the factors that supports market and the factors that are acting as impedance for the growth of the market.

Furthermore, the report includes the various trends and opportunities in the respective market in different regions for a better understanding of readers that helps to analyze the potential of the market.

Factors that are benchmarked while estimating the market

Various factors that are benchmarked while estimating the market growth includes (but not restricted to):

•    New product designs and launches

•    Current product compliance

•    Reimbursement

•    Concerns for use of Permanent Birth Control Drugs

•    Advantages of Permanent Birth Control Drugs

Actions taken by the manufacturer and respective regulatory authorities also impact the market growth of the segment. These factors are understood at regional level and in major countries globally for providing regional insights of the product segment in the report. This helps our clients to take informed decision.

A mix of top-down and bottom-up approach is followed to arrive and validate our market value estimations. For a product segment like wherein one/two manufacturer(s) dominates the market, it’s products sales, previous growth rates and market expansion plans are considered to generate market share in the global market.


To learn more about this report, request a free sample copy


1.    Global Permanent Birth Control Drugs Market Report Overview

1.1.    Introduction

1.2.    Report Description

1.3.    Methodology

2.    Global Permanent Birth Control Drugs Market Overview

2.1.    Introduction

2.1.1.    Introduction

2.1.2.    Market Taxonomy

2.2.    Executive Summary

2.3.    Global Permanent Birth Control Drugs Market Snapshot

2.4.    Global Permanent Birth Control Drugs Market Size and Forecast, 2020–2028

2.4.1.    Introduction

2.4.2.    Market Value Forecast and Annual Growth Rate (AGR) Comparison (2020–2028)

2.5.    Global Permanent Birth Control Drugs Market Dynamics

2.5.1.    Drivers

2.5.2.    Restraints

2.5.3.    Opportunity

2.5.4.    Trends

2.6.    Key Regulations

2.7.    Porter’s Five Forces Model

3.    Global Permanent Birth Control Drugs Market, By Product

3.1.    Introduction

3.1.1.    Annual Growth Rate Comparison, By Product

3.1.2.    BPS Analysis, By Product

3.2.    Market Revenue (US$Mn) Forecast, By Product

3.2.1.    Drugs

3.2.2.    Devices

3.2.2.1.    Intrauterine Devices (IUDs)

3.2.2.2.    Hormonal IUDs

3.2.2.3.    Copper IUDs

3.2.3.    Diaphragms

3.2.4.    Sponges

3.2.5.    Patches

3.2.6.    Implants

3.2.7.    Vaginal Rings

3.2.8.    Others

3.3.    Global Permanent Birth Control Drugs Market Attractiveness Index, By Product

4.    Global Permanent Birth Control Drugs Market, By Age Group

4.1.    Introduction

4.1.1.    Annual Growth Rate Comparison, By Age Group

4.1.2.    BPS Analysis, By Age Group

4.2.    Market Revenue (US$Mn) Forecast, By Age Group

4.2.1.    15‐24 years

4.2.2.    25‐34 years

4.2.3.    35‐44 years

4.2.4.    Above 44 years

4.3.    Global Permanent Birth Control Drugs Market Attractiveness Index, By Age Group

5.    Global Permanent Birth Control Drugs Market, By Education

5.1.    Introduction

5.1.1.    Annual Growth Rate Comparison, By Education

5.1.2.    BPS Analysis, By Education

5.2.    Market Revenue (US$Mn) Forecast, By Education

5.2.1.    Less Than High School

5.2.2.    High School Graduate

5.2.3.    College Graduate

5.2.4.    Other College Degrees

5.3.    Global Permanent Birth Control Drugs Market Attractiveness Index, By Education

6.    Global Permanent Birth Control Drugs Market, By End User

6.1.    Introduction

6.1.1.    Annual Growth Rate Comparison, By End User

6.1.2.    BPS Analysis, By End User

6.2.    Market Revenue (US$Mn) Forecast, By End User

6.2.1.    Household

6.2.2.    Hospitals

6.2.3.    Clinics

6.3.    Global Permanent Birth Control Drugs Market Attractiveness Index, By End User

7.    Global Permanent Birth Control Drugs Market, By Region

7.1.    Introduction

7.1.1.    Annual Growth Rate Comparison, By Region

7.1.2.    BPS Analysis, By Region

7.2.    Market Revenue (US$Mn) Forecast, By Region

7.2.1.    North America

7.2.2.    Latin America

7.2.3.    Europe

7.2.4.    Asia Pacific

7.2.5.    Middle East

7.2.6.    Africa

7.3.    Global Permanent Birth Control Drugs Market Attractiveness Index, By Region

8.    North America Permanent Birth Control Drugs Market Analysis and Forecast, 2020–2028

8.1.    Introduction

8.1.1.    Annual Growth Rate Comparison, By Country

8.1.2.    BPS Analysis, By Country

8.2.    Market Revenue (US$Mn) Forecast, By Country

8.2.1.    U.S. Permanent Birth Control Drugs Market

8.2.2.    Canada Permanent Birth Control Drugs Market

8.3.    North America Permanent Birth Control Drugs Market, By Product

8.3.1.    Drugs

8.3.2.    Devices

8.3.2.1.    Intrauterine Devices (IUDs)

8.3.2.2.    Hormonal IUDs

8.3.2.3.    Copper IUDs

8.3.3.    Diaphragms

8.3.4.    Sponges

8.3.5.    Patches

8.3.6.    Implants

8.3.7.    Vaginal Rings

8.3.8.    Others

8.4.    North America Permanent Birth Control Drugs Market, By Age Group

8.4.1.    15‐24 years

8.4.2.    25‐34 years

8.4.3.    35‐44 years

8.4.4.    Above 44 years

8.5.    North America Permanent Birth Control Drugs Market, By Education

8.5.1.    Less Than High School

8.5.2.    High School Graduate

8.5.3.    College Graduate

8.5.4.    Other College Degrees

8.6.    North America Permanent Birth Control Drugs Market, By End User

8.6.1.    Household

8.6.2.    Hospitals

8.6.3.    Clinics

8.7.    North America Permanent Birth Control Drugs Market Attractiveness Index

8.7.1.    By Country

8.7.2.    By Product

8.7.3.    By Age Group

8.7.4.    By Education

8.7.5.    By End User

9.    Latin America Permanent Birth Control Drugs Market Analysis and Forecast, 2020–2028

9.1.    Introduction

9.1.1.    Annual Growth Rate Comparison, By Country

9.1.2.    BPS Analysis, By Country

9.2.    Market (US$Mn) Forecast, By Country

9.2.1.    Brazil Permanent Birth Control Drugs Market

9.2.2.    Mexico Permanent Birth Control Drugs Market

9.2.3.    Argentina Permanent Birth Control Drugs Market

9.2.4.    Rest of Latin America Permanent Birth Control Drugs Market

9.3.    Latin America Permanent Birth Control Drugs Market, By Product

9.3.1.    Drugs

9.3.2.    Devices

9.3.2.1.    Intrauterine Devices (IUDs)

9.3.2.2.    Hormonal IUDs

9.3.2.3.    Copper IUDs

9.3.3.    Diaphragms

9.3.4.    Sponges

9.3.5.    Patches

9.3.6.    Implants

9.3.7.    Vaginal Rings

9.3.8.    Others

9.4.    Latin America Permanent Birth Control Drugs Market, By Age Group

9.4.1.    15‐24 years

9.4.2.    25‐34 years

9.4.3.    35‐44 years

9.4.4.    Above 44 years

9.5.    Latin America Permanent Birth Control Drugs Market, By Education

9.5.1.    Less Than High School

9.5.2.    High School Graduate

9.5.3.    College Graduate

9.5.4.    Other College Degrees

9.6.    Latin America Permanent Birth Control Drugs Market, By End User

9.6.1.    Household

9.6.2.    Hospitals

9.6.3.    Clinics

9.7.    Latin America Permanent Birth Control Drugs Market Attractiveness Index

9.7.1.    By Country

9.7.2.    By Product

9.7.3.    By Age Group

9.7.4.    By Education

9.7.5.    By End User

10.    Europe Permanent Birth Control Drugs Market Analysis and Forecast, 2020–2028

10.1.    Introduction

10.1.1.    Annual Growth Rate Comparison, By Country

10.1.2.    BPS Analysis, By Country

10.2.    Market (US$Mn) Forecast, By Country

10.2.1.    U.K. Permanent Birth Control Drugs Market

10.2.2.    Germany Permanent Birth Control Drugs Market

10.2.3.    Italy Permanent Birth Control Drugs Market

10.2.4.    France Permanent Birth Control Drugs Market

10.2.5.    Spain Permanent Birth Control Drugs Market

10.2.6.    Russia Permanent Birth Control Drugs Market

10.2.7.    Poland Permanent Birth Control Drugs Market

10.2.8.    BENELUX Permanent Birth Control Drugs Market

10.2.9.    NORDIC Permanent Birth Control Drugs Market

10.2.10.    Rest of Europe Permanent Birth Control Drugs Market

10.3.    Europe Permanent Birth Control Drugs Market, By Product

10.3.1.    Drugs

10.3.2.    Devices

10.3.2.1.    Intrauterine Devices (IUDs)

10.3.2.2.    Hormonal IUDs

10.3.2.3.    Copper IUDs

10.3.3.    Diaphragms

10.3.4.    Sponges

10.3.5.    Patches

10.3.6.    Implants

10.3.7.    Vaginal Rings

10.3.8.    Others

10.4.    Europe Permanent Birth Control Drugs Market, By Age Group

10.4.1.    15‐24 years

10.4.2.    25‐34 years

10.4.3.    35‐44 years

10.4.4.    Above 44 years

10.5.    Europe Permanent Birth Control Drugs Market, By Education

10.5.1.    Less Than High School

10.5.2.    High School Graduate

10.5.3.    College Graduate

10.5.4.    Other College Degrees

10.6.    Europe Permanent Birth Control Drugs Market, By End User

10.6.1.    Household

10.6.2.    Hospitals

10.6.3.    Clinics

10.7.    Europe Permanent Birth Control Drugs Market Attractiveness Index

10.7.1.    By Country

10.7.2.    By Product

10.7.3.    By Age Group

10.7.4.    By Education

10.7.5.    By End User

11.    Asia Pacific Permanent Birth Control Drugs Market Analysis and Forecast, 2020–2028

11.1.    Introduction

11.1.1.    Annual Growth Rate Comparison, By Country

11.1.2.    BPS Analysis, By Country

11.2.    Market (US$Mn) Forecast, By Country

11.2.1.    China Permanent Birth Control Drugs Market

11.2.2.    India Permanent Birth Control Drugs Market

11.2.3.    Japan Permanent Birth Control Drugs Market

11.2.4.    Australia and New Zealand Permanent Birth Control Drugs Market

11.2.5.    South Korea Permanent Birth Control Drugs Market

11.2.6.    ASEAN Permanent Birth Control Drugs Market

11.2.7.    Rest of Asia Pacific Permanent Birth Control Drugs Market

11.3.    Asia Pacific Permanent Birth Control Drugs Market, By Product

11.3.1.    Drugs

11.3.2.    Devices

11.3.2.1.    Intrauterine Devices (IUDs)

11.3.2.2.    Hormonal IUDs

11.3.2.3.    Copper IUDs

11.3.3.    Diaphragms

11.3.4.    Sponges

11.3.5.    Patches

11.3.6.    Implants

11.3.7.    Vaginal Rings

11.3.8.    Others

11.4.    Asia Pacific Permanent Birth Control Drugs Market, By Age Group

11.4.1.    15‐24 years

11.4.2.    25‐34 years

11.4.3.    35‐44 years

11.4.4.    Above 44 years

11.5.    Asia Pacific Permanent Birth Control Drugs Market, By Education

11.5.1.    Less Than High School

11.5.2.    High School Graduate

11.5.3.    College Graduate

11.5.4.    Other College Degrees

11.6.    Asia Pacific Permanent Birth Control Drugs Market, By End User

11.6.1.    Household

11.6.2.    Hospitals

11.6.3.    Clinics

11.7.    Asia Pacific Permanent Birth Control Drugs Market Attractiveness Index

11.7.1.    By Country

11.7.2.    By Product

11.7.3.    By Age Group

11.7.4.    By Education

11.7.5.    By End User

12.    Middle East Permanent Birth Control Drugs Market, By Region

12.1.    Introduction

12.1.1.    Annual Growth Rate Comparison, By Country

12.1.2.    BPS Analysis, By Country

12.2.    Market (US$Mn) Forecast, By Country

12.2.1.    GCC Countries Permanent Birth Control Drugs Market

12.2.2.    Israel Permanent Birth Control Drugs Market

12.2.3.    Oman Permanent Birth Control Drugs Market

12.2.4.    Rest of Middle East Permanent Birth Control Drugs Market

12.3.    Middle East Permanent Birth Control Drugs Market, By Product

12.3.1.    Drugs

12.3.2.    Devices

12.3.2.1.    Intrauterine Devices (IUDs)

12.3.2.2.    Hormonal IUDs

12.3.2.3.    Copper IUDs

12.3.3.    Diaphragms

12.3.4.    Sponges

12.3.5.    Patches

12.3.6.    Implants

12.3.7.    Vaginal Rings

12.3.8.    Others

12.4.    Middle East Permanent Birth Control Drugs Market, By Age Group

12.4.1.    15‐24 years

12.4.2.    25‐34 years

12.4.3.    35‐44 years

12.4.4.    Above 44 years

12.5.    Middle East Permanent Birth Control Drugs Market, By Education

12.5.1.    Less Than High School

12.5.2.    High School Graduate

12.5.3.    College Graduate

12.5.4.    Other College Degrees

12.6.    Middle East Permanent Birth Control Drugs Market, By End User

12.6.1.    Household

12.6.2.    Hospitals

12.6.3.    Clinics

12.7.    Middle East Permanent Birth Control Drugs Market Attractiveness Index

12.7.1.    By Country

12.7.2.    By Product

12.7.3.    By Age Group

12.7.4.    By Education

12.7.5.    By End User

13.    Africa Permanent Birth Control Drugs Market, By Region

13.1.    Introduction

13.1.1.    Annual Growth Rate Comparison, By Country

13.1.2.    BPS Analysis, By Country

13.2.    Market (US$Mn) Forecast, By Country

13.2.1.    South Africa Permanent Birth Control Drugs Market

13.2.2.    Egypt Permanent Birth Control Drugs Market

13.2.3.    North Africa Permanent Birth Control Drugs Market

13.2.4.    Rest of Africa Permanent Birth Control Drugs Market

13.3.    Africa Permanent Birth Control Drugs Market, By Product

13.3.1.    Drugs

13.3.2.    Devices

13.3.2.1.    Intrauterine Devices (IUDs)

13.3.2.2.    Hormonal IUDs

13.3.2.3.    Copper IUDs

13.3.3.    Diaphragms

13.3.4.    Sponges

13.3.5.    Patches

13.3.6.    Implants

13.3.7.    Vaginal Rings

13.3.8.    Others

13.4.    Africa Permanent Birth Control Drugs Market, By Age Group

13.4.1.    15‐24 years

13.4.2.    25‐34 years

13.4.3.    35‐44 years

13.4.4.    Above 44 years

13.5.    Africa Permanent Birth Control Drugs Market, By Education

13.5.1.    Less Than High School

13.5.2.    High School Graduate

13.5.3.    College Graduate

13.5.4.    Other College Degrees

13.6.    Africa Permanent Birth Control Drugs Market, By End User

13.6.1.    Household

13.6.2.    Hospitals

13.6.3.    Clinics

13.7.    Africa Permanent Birth Control Drugs Market Attractiveness Index

13.7.1.    By Country

13.7.2.    By Product

13.7.3.    By Age Group

13.7.4.    By Education

13.7.5.    By End User

14.    Recommendation

14.1.    Market Strategy

15.    Competitive Landscape

15.1.    Competition Dashboard

15.2.    List and Company Overview of Global Key Players

15.3.    Company Profiles

15.3.1.    The Female Health Company

15.3.1.1.    Company Overview

15.3.1.2.    Financial Overview

15.3.1.3.    Component Portfolio

15.3.1.4.    Key Developments

15.3.1.5.    Business Strategies

15.3.2.    Teva Pharmaceutical Industries Limited

15.3.3.    Mayer Laboratories

15.3.4.    Allergan plc

15.3.5.    Bayer AG

15.3.6.    Pfizer, Inc.

15.3.7.    Cooper Companies, Inc.

15.3.8.    Ansell LTD.

15.3.9.    Merck & Co., Inc.

15.3.10.    Church & Dwight, Co., Inc.

16.    Acronyms

Select License Type

Frequently Asked Questions

The global permanent birth control drugs market in 2020 is estimated for more than US$ 38,161.4 Mn and expected to reach a value of US$ 62,857.4 Mn by 2028 with a significant CAGR of 6.4%.

Increasing attention towards the prevention of unintended pregnancy and family planning, increase in the use of contraception in young women along with the rise in higher educational attainment propels the target market growth.

The permanent birth control drugs market is segmented on the basis of product, age group, education, end-user, and by region.

Some of the key participating players in the global permanent birth control drugs market are The Female Health Company, Teva Pharmaceutical Industries Limited, Mayer Laboratories Allergan plc, Bayer AG, Pfizer, Inc., Cooper Companies, Inc., Ansell LTD., Merck & Co., Inc., and Church & Dwight, Co., Inc.



This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy

OK